Next, if T cells are sensitized to tumors and have the ability to restrict tumor growth, we wanted to know whether treatment of tumor-bearing Hu-mice will benefit from anti-PD-1 therapy that is known to sustain tumor-infiltrating CD8+ T-cell activity1,9,12. Here, CD8A is linked to neoplasm.